LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
6.55
-0.20 (-2.96%)
Jan 12, 2026, 4:00 PM EST - Market closed
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $25.83 million as of January 12, 2026. Its market cap has increased by 23.01% in one year.
Market Cap
25.83M
Enterprise Value
1.52M
1-Year Change
23.01%
Ranking
Category
Stock Price
$6.55
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $493.00M to $25.83M, a decrease of -94.76%. That is a compound annual growth rate of -42.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 25.80M | -13.71% |
| Dec 31, 2025 | 29.90M | 31.72% |
| Dec 31, 2024 | 22.70M | -75.46% |
| Dec 29, 2023 | 92.50M | -22.85% |
| Dec 30, 2022 | 119.90M | -75.36% |
| Dec 31, 2021 | 486.70M | -56.26% |
| Dec 31, 2020 | 1.11B | 125.68% |
| Sep 18, 2020 | 493.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |